Our areas of partnering interest
Home / Partnering / Our areas of partnering interest
您是否想知道您的新科学或技术是否会引起澳门在线赌城娱乐的兴趣?
以下是澳门第一赌城在线娱乐热衷于探索合作机会的关键领域的总结.
-
Oncology
-
Cardiovascular, Renal and Metabolism
-
Respiratory & Immunology
-
Vaccines and Immune Therapies
-
Precision Medicine
-
Enabling technologies
Oncology
We have a bold ambition to provide cures for cancer in every form. 澳门第一赌城在线娱乐正在跟随科学去了解癌症及其所有的复杂性, 开发和提供改变生活的治疗方法，提高拯救世界各地人民生命的潜力.
以不同的方式思考:澳门在线赌城娱乐如何通过行业领先的交易在竞争激烈的肿瘤领域找到价值
Cardiovascular, Renal and Metabolism
Our bold ambition is to stop, reverse and cure CVRM diseases by maximising our medicines, delivering innovative solutions, and advancing our pipeline.
Respiratory & Immunology
澳门第一赌城在线娱乐致力于改变对一些最使人衰弱的慢性呼吸道疾病和免疫介导疾病的护理. Our portfolio of inhaled and biologic medicines, and our pipeline for the future, 寻求解决患者今天面临的挑战和大量未满足的医疗需求.
Vaccines and Immune Therapies
澳门第一赌城在线娱乐致力于开发和提供变革性疫苗和抗体, providing long lasting immunity for millions of people, where the burden of disease is greatest.
Precision Medicine
澳门第一赌城在线娱乐90%以上的临床产品线现在都遵循精准医疗方法. 澳门第一赌城在线娱乐与广泛的合作伙伴合作，验证和开发符合全球监管标准的诊断设备, 并将创新的生物标志物能力商业化，用于患者选择, disease identification and drug response. These collaborations cover a broad range of cutting-edge technologies, such as tumour tissue diagnostics, molecular tests, and point-of-care diagnostics.
Enabling technologies
Collaboration opportunities in China, Japan and other international markets
No matter where in the world you may be located, 澳门第一赌城在线娱乐有兴趣在澳门第一赌城在线娱乐的主要治疗领域和其他领域与您探索领先的合作机会. 澳门第一赌城在线娱乐仔细考虑当地的医疗情况，并采取灵活的方法，使澳门第一赌城在线娱乐能够满足关键市场中患者的特定需求.
In China, for example, 澳门第一赌城在线娱乐正在探索支持和增强澳门第一赌城在线娱乐现有商业实力的机会. Our focus is on partnering opportunities from R&D through commercial launch stage, in areas such as paediatric, nebulised, pulmonary, gastric, cardiovascular, and traditional Chinese medicine.
In Japan, 澳门第一赌城在线娱乐希望与一系列专家合作，帮助改变医疗实践和患者的生活. We focus on opportunities at or near commercial launch stage in the areas of oncology; cardiovascular, renal and metabolism; and respiratory and immunology.
澳门第一赌城在线娱乐的兴趣不仅限于医药产品，还包括诊断、设备和数字技术. 澳门第一赌城在线娱乐的目标是与一系列合作伙伴合作，建立端到端的患者解决方案，帮助提高疾病意识, diagnosis, treatment and post-treatment care. 虽然这些伙伴关系旨在满足当地患者未得到满足的医疗需求, some also have potential to benefit patients globally.
Using our presence and reach, we can also help you commercialise your product in China, Japan and other international markets. Together with the China International Capital Corporation (CICC), we established the AstraZeneca-CICC Healthcare Investment Fund, 这是一家私募股权基金，通过投资医药和生物技术等领域，促进中国医疗保健创新的发展, diagnostics, medical devices and digital health.
Veeva ID: Z4-49876
Date of preparation: November 2022